Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter—still a dilemma?
| Autor: | Hegi, M.E., Stupp, R. |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2015 |
| Předmět: |
Dacarbazine
DNA Repair Enzymes Brain Neoplasms Tumor Suppressor Proteins Editorials Temozolomide Humans Antineoplastic Agents DNA Methylation Glioblastoma Promoter Regions Genetic DNA Modification Methylases Antineoplastic Agents/therapeutic use Brain Neoplasms/drug therapy Brain Neoplasms/genetics DNA Methylation/genetics DNA Modification Methylases/genetics DNA Repair Enzymes/genetics Dacarbazine/analogs & derivatives Dacarbazine/therapeutic use Glioblastoma/drug therapy Glioblastoma/genetics Promoter Regions Genetic/genetics Tumor Suppressor Proteins/genetics |
| Zdroj: | Neuro-oncology, vol. 17, no. 11, pp. 1425-1427 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|